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Vasopressin-stimulated movement of drugs and uric acid across the
toad bladder. Vasopressin is known to increase the permeability of
the toad bladder, an analogue of the mammalian collecting duct, to
water and hydrophilic solutes such as urea. In the present study,
the effect of vasopressin on the permeability of a series of lipophilic
compounds, including many commonly used drugs, has been deter-
mined. In all cases, permeability increased from 50 to 100%. The
response to vasopressin was mediated by cyclic adenosine mon-
ophosphate (cAMP), and was generally not altered by phloretin,
an agent that inhibits amide movement through the amide transport
pathway. Evidence that these compounds move directly through
the lipid phase of the membrane was provided in studies of pheno-
barbital permeability at low and high luminal pH. We would con-
clude from these studies that the effect of vasopressin on the lu-
minal cell membrane is a widespread one, modifying both lipid
components and components involved in amide, sodium and water
transport. This may be of importance in the renal tubular reabsorp-
tion of many drugs, including barbiturates, glutethimide and anti-
biotics.
Mouvements d'acide urique et de drogues, a travers Ia vessie du
crapaud, stimulés par Ia vasopressine. II est connu que Ia vasopres-
sine augmente Ia perméabilité de Ia vessie de crapaud, qui est
analogue au canal collecteur des mammifères, a l'eau et aux sub-
stances dissoutes hydrophiles comme l'urée. Dana cc travail a été
étudié l'effet de Ia vasopressine sur La perméabilité de cette struc-
ture a une série de composes lipophiles incluant plusieurs drogues
communément utilisées. La réponse a Ia vasopressine a I'AMP
cyclique comme médiateur et n'est pas modifée, Ic plus souvent,
par Ic phloretin, un corps qui inhibe les mouvements d'amide en
agissant sur La voie de transport des amides. La preuve de ce que les
composes étudiés se meuvent dans Ia phase lipidique de Ia mem-
brane a été apportée parl'étude des perméabilités au phénobarbital
a des pH luminaux bas et haut. Nous concluons de ces etudes que
l'effet de Ia vasopressine sur Ia membrane cellulaire luminale est un
effet diffus, qui affecte a Ia fois les composants lipidiques et ceux
impliques dans les transports d'amide, de sodium et d'eau. Cela
peut être important dans Ia reabsorption tubulaire rénale de plu-
sieurs drogues, y compris les barbiturates, Ia glutethimide et les
antibiotiques.
Vasopressin increases the permeability of receptor
cells to water, and to hydrophilic solutes such as urea
and other amides [1-41. A recent study in the toad
bladder by Pietras and Wright [5J has described a
small but definite effect of vasopressin on lipophilic
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solutes as well, with compounds such as caffeine in-
creasing their permeability by 30% following adminis-
tration of the hormone. This finding is of particular
interest in relation to the effect of vasopressin on the
renal reabsorption of commonly used drugs, many of
which are highly lipophilic. We have therefore deter-
mined the effect of vasopressin on the movement of a
series of therapeutic agents and other lipophilic so-
lutes across the toad bladder, and have found that
vasopressin accelerates the movement of all solutes
tested. This is of interest not only in relation to drug
metabolism, but in relation to the mechanism of ac-
tion of vasopressin on the cell membrane.
Methods
Female toads (National Reagents, Bridgeport, CT)
were doubly pithed, and glass bungs tied into both
hemibladders in situ. The bladders were removed and
filled with 8 ml of phosphate-buffered Ringer's solu-
tion (120 m Nat; 4.0 mvi K; 0.5 mM Ca; 116
m Cl-; mrvi phosphate, pH 7.4; 230 mOsm/kg of
H20). The bladders were washed inside and out three
times with fresh Ringer's to remove any endogenous
vasopressin, and were finally refilled with 8 ml of
Ringer's containing the isotope to be tested. The blad-
ders were then suspended in 30 to 35 ml of Ringer's.
Stirring was provided by magnetic stirrers inside and
out for the more permeable compounds (baseline
Ktrans > 20 X 10 cm/sec) to minimize the effect of
unstirred layers on measured permeability [6].
Where osmotic water flow was to be determined,
Ringer's diluted 1:10 with distilled water was sub-
stituted for the full-strength Ringer's in the luminal
washes and bath. In studies with phenobarbital,
Ringer's buffered by 4 mrst phthalate to pH 5.0, or 5
mM Tris to pH 9.0, was substituted for the phosphate
Ringer's in the luminal washes and bath. Full-
strength phosphate Ringer's, pH 7.4, was always used
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for the serosal washes and bath. The permeability of
14C-butanol was measured in the mechanically stirred
Lucite chambers previously described [6], in order to
minimize the effects of unstirred layers on this very
permeable compound. The permeability coefficient
(Ktrans) of each isotopic species was determined by
sampling the serosal and luminal bathing media at
timed intervals [4]. Samples were pipetted into Aqua-
sol (New England Nuclear Corp., Boston, MA) and
counted in a liquid scintillation counter (Tri-Carb,
Packard Instrument Co., LaGrange, IL. Water move-
ment was determined by carefully blotting the bags
and weighing them [7]. '4C-5-fluorouracil and cyclo-
hexanone were obtained from the International
Chemical and Nuclear Corp., Irvine, CA; 3H-glu-
tethimide (Doriden), tetracycline, '4C-phenobarbital,
diphenylhydantoin (Dilantin), adenine, chioram-
phenicol and butanol from the New England Nuclear
Corp., Boston, MA; and '4C-isoniazid and uric acid
from the Amersham/Searle Corporation, Arlington
Heights, IL. Vasopressin (Pitressin) was obtained
from Parke-Davis, Detroit, MI, phloretin from
K & K Laboratories, Plainview, NY, and 3'5'-cyclic
adenosine monophosphate (cAMP) from Sigma
Chemical Company, St. Louis, MO. In all experi-
ments, results obtained in test hemibladders were
compared with those from control hemibladders by
the method of paired analysis [8]. Verification of the
purity of the isotope appearing in the serosal bath
was obtained by thin-layer chromatography for
phenobarbital [9], diphenylhydantoin [10] and glu-
tethimide [9]. Dr. Ruth Abramson determined the
purity of the '4C-uric acid [11]. Decanol: water parti-
tion coefficients (Kdec) for the isotopes tested were
measured by the method of Tosteson et al [12].
Results
Compounds tested. The compounds investigated
are shown in Fig. 1, together with their decanol: wa-
ter partition coefficients (Kdec). A low Kôec (e.g., uric
acid) indicates far greater solubility in water than in
decanol; a high Kdec (e.g., phenobarbital, glutethi-
mide, diphenylhydantoin) indicates the opposite. The
compounds tested included three amides: tetracy-
cline, chloramphenicol and isoniazid; five imides
(ring compounds in which a nitrogen adjoins a carbo-
nyl): uric acid, fluorouracil, phenobarbital, glutethi-
mide and diphenylhydantoin; and three compounds
which are unrelated to either of these two groups:
adenine, butanol and cyclohexanone.
Effect of vasopressin on isotope permeability. Paired
bladder halves filled with Ringer's, pH 7.4, were used.
Control and test hemibladders were treated identi-
cally during the 15-mm baseline period I, at the end
of which 86 mU/mI of vasopressin was added to the
serosal medium of the test hemibladders. Isotope per-
meability was then measured for an additional 30-
Compound
Uric acid 0.004
5-Fluorouracil NF 0.095
N C2H5
o=jx.n—
C2 H5
Glutethimide 0xitiI
Diphenyihydantoin
160
NH2NN
Adenine I 1 C 0.44
OH 0 OH 0 o
Tetracycline
::1::IItIII:::1I:[
0.10
H3C OH N(CH3)2
OHCH2OHO
Chloramphenicol NO2O C— C— NH—C— CHCI2 9.3
OH/ ii I
Isoniazid N
—
C—N—NH2 0.11
Butanol CII3CH2CH2CH2OH 4.5
Cyclohexanone O 4.6
Fig. 1. Compounds tested in the present study, with structural for-
mulas and decanol: waler partition coefficients.
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mm period. Ktrans butanol was measured in cham-
bers for one 20-mm baseline and one 20-mm experi-
mental period. The effect of vasopressin on the per-
meability of the compounds tested is shown in Table
I. All of the compounds tested showed a significant
increase in permeability after vasopressin. The in-
crease in permeability ranged from 13% for butanol
to 140% for diphenylhydantoin, and was seen even in
the most lipid-soluble molecules tested.
Effect of cyclic AMP and theophylline on diphen-
ylhydantoin permeability. To determine whether the
post-vasopressin increase in permeability of the lipid-
soluble substances tested is, like that of amides and
water, mediated by increased formation of adenosine
3',5'-cyclic monophosphate (cyclic AMP), the effect
of this nucleotide on Ktrana diphenylhydantoin was
determined. After measurement of Ktrang diphenylhy-
dantoin for a 15-mm baseline period (period I, Table
2), the serosal bath of the test hemibladders was re-
placed with Ringer's containing 10 m cyclic AMP,
and Ktrans determined for an additional 30-mm pe-
riod (period II). Control hemibladders were treated
similarly, but received no cyclic AMP. A significant
increase in Ktrana diphenylhydantoin was seen in the
test bladders after cyclic AMP administration.
In order to determine whether maximal stimu-
lation by cyclic AMP was comparable to the effect of
vasopressin, an additional series of experiments was
performed in which the test bladders received 3 mM
theophylline in addition to 10 m cyclic AMP at the
end of period I. As shown in the bottom of Table 2,
cyclic AMP and theophylline caused an approximate
doubling of Ktrans diphenylhydantoin, an effect com-
parable to that of 86 mU/ml of vasopressin.
The effect of alteration of lipid solubility on Ktrans
phenobarbital. To be certain that the permeabilities of
the compounds tested, both before and after vaso-
pressin administration, represented their movement
through the lipid rather than the aqueous phase of
the membrane, experiments were performed in which
the lipid solubility of 14C-phenobarbital was altered
by reducing the pH of the luminal bath to 5.0, or
raising it to 9.0. The concentration of the lipid-sol-
uble or nonionized form of phenobarbital is
markedly altered by this change in PH; at pH 5.0,
phenobarbital, which has a pK of 7.3, is over 99% in
the lipid-soluble form, and Kôecanoi is 17.5; at pH 9.0,
only 2% is nonionized, and Kdecanol is only 0.5. As
shown in Fig. 2, both baseline and vasopressin-stimu-
lated phenobarbital permeabilities changed in paral-
lel with lipid solubility, suggesting that lipid solubility
was indeed the major determinant of transport both
before and after vasopressin administration. The ab-
sence of effect of pH on the movement of glutethi-
mide (which has a pK of 11.8, so that the proportion
of the nonionized form is high even at pH 9), and on
urea and osmotic water flow, suggests that the de-
crease in phenobarbital permeability at pH 9 can be
attributed to alterations in lipid solubility of the
phenobarbital, and not to changes in the bladder
induced by high pH.
The effect of phloretin on isotope permeability. Pre-
vious studies [13] have shown that phioretin, the aglu-
cone of phlorizen, blocks the transport of amides,
and certain nonamides (thiourea and formaldehyde)
across the toad bladder. The effect of phloretin on the
movement of isoniazid, phenobarbital, glutethimide
and diphenylhydantoin was therefore determined.
Table 1. Effect of vasopressin on isotope permeability
Isotope
Ktra,,, cm/sec X 1fF
Control hemibladder Test hemibladder
(I1-I)tt(III)coatroI II I II
Uric acid (6)
Adenine(5)
5-Fluorouracil (4)
Tetracycline(4)
Chloramphenicoi (4)
lsoniazid(4)
Phenobarbital (6)
Diphenylhydantoin(4)
Glutethimide (6)
Cyclohexanone(5)
N-Butanol(5)
1.1
1.0
1.2
6.3
9.7
11.4
24.7
54
707
1633
2873
+ 0.2" 1.3 + 0.2
+ 0.1 0.8 + 0.1
+ 0.1 1.1 0.1
1.1 4.5 0.6
1.3 7.7 + 0.6
1.6 10.2 + 1.2
+ 5.3 21.5 + 3.7
14 59 13
43 757 + 77
+ 184 1247 102
95 2791 + 118
1.1 0.1 2.1 0.3
1.7 0.4 2.4 0.4
1.0 0.2 2.0 0.1
5.5 0.3 6.4 + 0.3
9.5 1.2 12.0 + 1.6
11.6 1.3 15.9 1.6
25.3 6.1 45.8 7.5
46 7 115 + 21
655 + 26 945 49
1278 146 1386 171
2816 196 3094 224
0.8 0.2e
0.8 Ø3c
1.1 0.4e
2.7 + Ø•6d
4.5 1.2c
5.4 1.Od
23.7 + 37e
65 + 15e
243 45
493 + l80
360 + 105C
a Number of experiments.
b
1 SEM.P < 0.05.
d P < 0.02.
ep < 0.0!.
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Table 2. Effect of cyclic AMP and theophylline Ofl Ktrn, 4C-diphenylhydantoin
Ktran, cm/sec X I0
I LI (iL_I )tet(lli)conroi
tO mM cyclic AMP(6)
Test
Control
10 mM cyclic AMP + 3 mM
Test
Control
87.7 + 11.0
86.5 + 13.0
theophylline (4)
87.8 + 8.1
79.3 3.5
99.7 14.7
75.3 10.7
155.0 15.5
72.5 + 9.6
23.2 + 5.6; P <
74.0 4.5; P <
0.01
0.001
Test hemibladders contained l04M phloretin in 0.5%
ethanol added to the luminal bath. Control hemiblad-
ders received 0.5% ethanol alone. Figure 3 shows the
effect of phloretin on the isotopes tested after the
addition of vasopressin, as well as on other isotopes
tested previously [13]. Of the compounds tested in the
present study, only the permeability of the amide
isoniazid was depressed by phloretin, while per-
meabilities of the non-amides were unaltered.
Discussion
The present study shows that vasopressin increases
the permeability of the toad urinary bladder to every
compound tested, from uric acid (virtually insoluble
in lipid) to highly lipid-soluble compounds such as
glutethimide, cyclohexanone and butanol.
Our findings have several implications for our un-
derstanding of the mechanism of action of vasopres-
sin. First, in contrast to earlier proposals that vaso-
pressin opens aqueous channels in the luminal
membrane, permitting water and small hydrophilic
solutes to penetrate the membrane at a more rapid
rate [2, 14], the present findings support the view that
the hormonal effect is a widespread one, which may
transform both the lipid and protein phases of the
membrane. Earlier studies have shown that independ-
ent membrane pathways exist for water, amides and
non-amides in the vasopressin-treated toad bladder
[3, 13]. We now would add a cyclic AMP-mediated
pathway for highly lipophilic solutes, suggesting that
the fluidity of the entire lipid phase of the luminal
membrane may be altered by vasopressin [5]. We
may therefore view the action of the hormone as both
a broad one with respect to membrane lipid, in which
the permeability to lipophilic molecules increases
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Fig. 2. Permeabilities of labeled phenobarbital, glutethimide and
urea, and osmotic water flow in bladders with luminalpH 5.0 and 9.0.
Serosal pH was 7.4 in all bladders. Shaded bars represent control
periods; open bars represent increment after addition of vasopres-
sin.
K decanol
Fig. 3. Effect of 10-4M phloretin on the movement of solutes across
vasopressin-treated bladders. Percentage depression or acceleration
is shown for bladders receiving phloretin plus vasopressin com-
pared to bladders receiving vasopressin alone. Vertical bars: + 1
SEM.
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nonselectively from 50 to 100%, and a more specific
one with respect to the transport pathway for amides
such as urea, whose permeability may increase by
ten-fold. Pietras and Wright [5] have suggested that a
change in the fluidity of the membrane lipid might
account for the increased permeability of both lip-
ophilic and hydrophilic solutes if, for example, vaso-
pressin caused a relatively larger increase in the fluid-
ity at the polar head groups of the lipid than in the
hydrophobic "core" of the membrane. The fact that
phloretin, which inhibits amide transport, has no de-
tectable effect on the permeability of lipophilic so-
lutes' points to a second possibility: that phioretin (as
well as tannic acid and chromate [15]) blocks a pro-
tein pathway through the membrane which is parallel
to the pathway for lipophilic solutes. In synthetic
lipid bilayers, phioretin increases the permeability of
the amide acetamide by two-fold, rather than decreas-
ing it (Finkelstein A., unpublished observations), pro-
viding additional evidence that amide movement
across the toad bladder does not proceed through a
simple lipid barrier. As far as water and sodium trans-
port are concerned, the role of vasopressin-induced
changes in membrane lipid is not established.
The failure to detect a generalized vasopressin ef-
fect in prior experiments [161 was probably due to
edge damage associated with the Lucite chambers
used in these studies [17], so that a small vasopressin
effect could have been obscured by the leak at the
bladder edge. The present bag preparations have a
considerably higher surface area-to-edge ratio and
thus would tend to be less affected by edge damage.
In addition, unstirred layers in the magnetically
stirred bags may be less important than in the cham-
bers which were stirred by air-lift only.
Turning to clinical implications of this study, our
findings suggest, by analogy, that vasopressin en-
hances distal nephron reabsorption of drugs in man.
This would have no detectable effect on the clearance
of a compound such as uric acid, whose permeability
across the toad bladder is virtually zero both before
and after vasopressin administration; however, the
clearance of more permeable molecules such as
diphenylhydantoin and glutethimide would be ex-
pected to be lower in the presence than in the absence
of vasopressin. Our results support the accepted clini-
cal practice of maintaining high urine flows in
patients with drug overdose, and suggest in addition
that renal reabsorption of agents such as glutethimide
and phenobarbital may be further depressed if vaso-
pressin levels are low. This possible advantage must,
'Owen and Solomon [18] have reported a significant enhance-
ment of the permeability of lipophilic molecules across the eryth-
rocyte membrane by phloretin; this was not apparent in the toad
bladder.
of course, be weighed against the danger of fluid
overload in such patients.
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